Alkyllithium Cyclizations in Organic Snythesis
有机合成中的烷基锂环化
基本信息
- 批准号:6722807
- 负责人:
- 金额:$ 23.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Synthetic chemistry is the technology
underlying modern drug development. The successful mapping of the human genome
was the first step towards identifying new receptors and pathways to treat
chronic diseases. The path from bimolecular targets to realizing improvements
in human health usually requires the synthesis of small molecule agonists,
antagonists, or inhibitors. In this proposal we will develop a potentially
powerful method to synthesize small nitrogen and oxygen spiro rings. New
synthetic methods such as this one are an enabling technology for improving
human health.
The reductive cleavage of nitrile is a rarely used method for generating
alkyllithium reagents. In many six-membered rings this reaction is completely
stereoselective, and the resulting alkyllithium will couple with electrophiles
with retention of configuration. We propose to use this reductive lithiation
reaction, in combination with facile alkylations adjacent to nitrile groups, to
develop a general and stereoselective synthesis of spiro rings. This method
will be developed to prepare the spiro-tetrahydropyran rings. These reductive
cyclization reactions will be used in a general synthesis of
contrathermodynamic spiroacetals, structures commonly found in complex natural
products. The third area of development is in the synthesis of
spiropiperidines, where modification of the substrate will allow either
configuration of the spiropiperidine to be prepared selectively.
The synthetic targets for this proposal are segments of natural products and
natural products themselves. Segments of altohyrtin (spongistatin) and
azaspiracid will be prepared using the approach to contrathermodynamic
spiroacetals. Histrionicotoxin and pinnaic acid will be prepared using the
spiropiperidine method. These compounds are of interest to synthetic and
medicinal chemists, and have the types of rigid, polycyclic and polar
structures found to show high bioactivity in many assays.
描述(申请人提供):合成化学是一门技术
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT D. RYCHNOVSKY其他文献
SCOTT D. RYCHNOVSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT D. RYCHNOVSKY', 18)}}的其他基金
ACQUISITION OF A 500 MHZ NMR SPECTROMETER: CHEMISTRY
获取 500 MHZ 核磁共振波谱仪:化学
- 批准号:
6973228 - 财政年份:2004
- 资助金额:
$ 23.21万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6522261 - 财政年份:2001
- 资助金额:
$ 23.21万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6400176 - 财政年份:2001
- 资助金额:
$ 23.21万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6619600 - 财政年份:2001
- 资助金额:
$ 23.21万 - 项目类别:
Synthesis of anticancer agents using Prins cyclization
使用 Prins 环化合成抗癌药物
- 批准号:
6865345 - 财政年份:1998
- 资助金额:
$ 23.21万 - 项目类别:
相似海外基金
NIH resubmission Deyu Li - Etheno adductome and repair pathways
NIH 重新提交 Deyu Li - 乙烯加合组和修复途径
- 批准号:
10659931 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
- 批准号:
10735154 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Novel Triple-Negative Breast cancer vulnerability governed by PNPT1-mediated RNA decay
由 PNPT1 介导的 RNA 衰变控制的新型三阴性乳腺癌脆弱性
- 批准号:
10606114 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation
靶向免疫反应基因 1 (Irg1) 和衣康酸对移植供体心脏进行心脏保护
- 批准号:
10895712 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
碳水化合物和糖复合物的化学合成和生物应用
- 批准号:
10552167 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
DNAzymes for Site-Specific DNA and RNA Nucleobase Modification
用于位点特异性 DNA 和 RNA 核碱基修饰的 DNAzyme
- 批准号:
10630686 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Translational regulation by covalent modification of mRNA
通过 mRNA 共价修饰进行翻译调控
- 批准号:
10789242 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
N6-Methyladenosine Methylome in Duchenne Muscular Dystrophy
N6-甲基腺苷甲基化在杜氏肌营养不良症中的应用
- 批准号:
10593310 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Shu complex and RAD52 function in DNA damage recognition and subsequent repair
Shu 复合物和 RAD52 在 DNA 损伤识别和后续修复中发挥作用
- 批准号:
10864084 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:














{{item.name}}会员




